drugset / Trial / NCT00107965
Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Actinic Keratoses
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to determine whether topical application of PEP005 is safe for the treatment of actinic keratoses.
Timeline
- Start
- 2005-03
- Primary completion
- 2005-09
- Completion
- 2005-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | ingenol mebutate | Small molecule | 0.0025 % | Topical |
| Comparator | ingenol mebutate | Small molecule | 0.01 % | Topical |
| Comparator | ingenol mebutate | Small molecule | 0.05 % | Topical |